Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Download PDF
April 18, 2016
/
News
Share
the Post
Related
Posts
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
